NEFL and oculocutaneous albinism type 1: The ATN classification system incorporates biomarkers of amyloid‐β (Aβ) and tau pathologies along with non‐specific markers of neurodegeneration and neuronal injury such as neurofilament light (NfL) polypeptide (Jack, Bennett, et al. 2016).